Bentham Science Logo

Track Your Manuscript:

Current Drug Metabolism

Volume 21, 14 Issues, 2020
ISSN: 1875-5453 (Online)
ISSN: 1389-2002 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Meet the Executive Guest Editor(s)

W. Cai
Hunan University of Medicine
Dr.Wei Cai received his Ph.D degree from Beijing University of Chinese Medicine in 2015. He is currently an associate professor at school of pharmaceutical science, Hunan University of Medicine. During 2017-2018, he was a visiting scholar at Yale University under the supervision of Prof.Yung-Chi Cheng. He is especially interested in metabolism and pharmacokinetics of traditional Chinese medicine. He has published more than 30 peer-reviewed papers.

S. Chatterjee
Bristol-Myers Squibb
New York, NY
(United States)
Dr. Sagnik Chatterjee currently serves as a senior research investigator in BBRC, Bangalore. His group is working on impact of transporters in disposition, toxicity and efficacy of molecules, in normal and in disease conditions. He completed his M. S (Pharm) from NIPER, Mohali, India in natural products chemistry (2005-2007) and then obtained his PhD degree from KU Leuven, Belgium in exploring drug-induced cholestasis (2010-2014). He developed and validated a sandwich- cultured hepatocyte-based system, with externally added bile acids, that is widely accepted and recommended by International Transporter Consortium. Before PhD he worked with AstraZeneca India, in their drug metabolism group (2007-2009). He has published in 9 peer-reviewed articles with present citations tally of 290.

H. Ding
University of Electronic Science and Technology of China
Dr. Hui Ding is the associate Professor of Center for Informational Biology at University of Electronic Science and Technology of China. She received her Ph.D. from Inner Mongolia University, P.R. China in 2009. Her research is in the areas of computational system biology. She has published over 60 peer-reviewed papers in SCI-indexed journals. Her publications have been cited over 3,406 times with H-index of 31 in Google Scholar (update in 2019.8).

G. Ianiro
Fondazione Policlinico Universitario “A. Gemelli”
Dr. Ianiro received his medical degree in 2009 summa cum laude at the Catholic University of Rome.He trained in gastroenterology at the same University. He is currently gastroenterologist at the Digestive Disease Center of the Fondazione A. Gemelli IRCCS, Università Cattolica del Sacro Cuore in Rome, Italy. He has since gone on to establish himself as a key clinical and translational investigator focusing mainly in the field of intestinal microbiota with 99 peer reviewed publications including some of the best referral journal in Gastroenterology and Internal Medicine, including NEJM, Circulation, Annals of Internal Medicine, Gut, Nature Reviews Gastroenterology and Hepatology, Pharmacology &Therapeutics, Clinical Gastroenterology & Hepatology, Alimentary Pharmacology & Therapeutics, etc.). He was the secretary of two international consensus conferences on fecal microbiota transplantation. He was in the Young Talent Group, and now is in the Research Committee, of the UEG (United European Gastroenterology). Dr. Ianiro has received several research grants in support of his innovative research (the most recent from the Italian Ministry of Health as PI for a project entitled "Targeting gut microbiota to improve efficacy of immune checkpoint inhibitors in patients withadvanced renal cell carcinoma").

M.A. Kamal
King Abdulaziz University
(Saudi Arabia)
Dr. Mohammad Amjad Kamal is a Distinguished Adjunct Professor at the King Fahd Medical Research Center (KFMRC), King Abdulaziz University, Saudi Arabia. He is leading a highly productive global collaborative research team based from Novel Global Community Educational Foundation (NGCEF), Australia. Dr. Kamal's biochemical research in the field of Alzheimer’s disease, Type 2 diabetes and leukemia has culminated in more than 380 publications in internationally respected journals. Dr. Kamal was awarded a prestigious U2000 Postdoctoral Fellowship in 2000 by the University of Sydney. This three years highly competitive award funded his research on the "Inhibition of amido phosphoribosyltransferase by new antifolates". Amongst numerous projects, Dr. Kamal also collaborated on the molecular biological research project “Linkage of Alzheimer’s disease and Type 2 diabetes” at the University of Technology, Sydney. Moreover, he is serving as an EiC/regional/editorial member/guest editor of several reputed scientific journals on honorable basis.

S. Kar
Jackson State University
Jackson, MS
Dr. Supratik Kar is a research associate at Jackson State University, Mississippi, USA. He has completed his B. Pharm. (2008) and M. Pharm. (2010) degree from Jadavpur University (Kolkata, India) securing first position in both degrees and earned his PhD (2015) from the Jadavpur University (Kolkata, India). He is a Former visiting researcher at the University of Gdańsk (Poland). Dr. Kar has been working and gaining experience in molecular modeling studies for ten years. He has published 50 research and review articles, 9 book chapters till date with h-index 20. He has also co-authored 2 QSAR related books in Academic press and Springer. He is also the Reviewer of more than 15 reputed journals. ORCID:

K. Kunimasa
Osaka International Cancer Institute
Dr. Kei Kunimasa, (born December 25, 1981, Hyogo, Japan), studied medicine at Osaka University, graduating with an M.D. in 2006. He later also received a Ph.D. (2016) in medical science from Kobe University. While a graduate student, he researched cell competition using Drosophila melanogaster and found Sas (stranded at second) controls cell competition between normal cell and neighboring cancer cell (Nature. 2017), and he also researched cancer metabolism under Tatsuya Nagano (Cancer Science. 2018). From 2017, he worked at Osaka International Cancer Institute as senior staff and researched clinical cancer genomics using next generation sequencing with human samples. He also won the fund from Japan Society for the Promotion of Science (JSJP)(2019) and Takeda science foundation(2019).

M.F. Maida
A.O. Ospedali Riuniti S. Elia-Raimondi
Dr. Marcello Maida graduated from the medical school at University of Palermo. He is a consultant gastroenterologist at S.Elia- Raimondi Hospital in Caltanissetta, Italy, member of the governing council of the Young Italian Gastroenterologists Association (AGGEI) and Director of the Multimedia Educational Platform of Italian Medical Schools of Gastroenterology (Gastrolearning). He is author of several scientific papers indexed on PubMed and published in impact factor journals. Dr. Maida’s research interests include several areas of liver diseases, including hepatocellular carcinoma, viral hepatitis, autoimmune liver diseases, cirrhosis and non-invasive evaluation of chronic liver diseases.

T. Nagano
Kobe University
Dr. Nagano obtained a Ph.D. from the Kobe University Graduate School of Medicine (Kobe, Japan). Dr. Nagano also received M.D. from the Kobe University Graduate School of Medicine and has a 17 years’ experience as physician in general hospital. Currently Dr. Nagano is an Assistant Professor in the Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine. His present research field is clinical pharmacology in cancer pharmacotherapy. He has published more than 40 scientific publications and has 1 patent. Dr. Fujita is currently the Executive Guest Editor of this journal (Current Drug Metabolism).

R. Nakov
Tsaritsa Yoanna University Hospital
Dr. Nakov is a consultant gastroenterologist at Tsaritsa Yoanna University Hospital, Sofia. He obtained a doctorate (PhD) in Gastroenterology from the Medical University of Sofia. Dr. Nakov is a member of Young Talents Group and Education Committee at United European Gastroenterology (UEG), a course director of UEG Summer School and a president at Association for young hepatogastroenterologists in Bulgaria.

H. Orhan
Ege University
Hilmi Orhan is a Professor in the Department of Toxicology at Ege University, Izmir, Turkey. He obtained his Ph.D. in Pharmaceutical Toxicology from Hacettepe University in 2000. He was a visiting fellow at Vrije Universiteit, The Netherlands in 1995. During his Ph.D., he received a Turkish Scientific and Technical Research Council (TUBITAK) /NATO A2 grant and researched the Division of Molecular Toxicology from the same university on the biotransformation and toxicity of volatile anesthetics (1997–1999). Dr. Orhan has authored or co-authored 40 publications in peer-reviewed international journals and 18 publications in local journals. He has taught toxicology to both graduate and undergraduate levels and has successfully supervised eight M.Sc. and several Ph.D., students.

P.S. Pereira
Universidade Regional do Cariri
Dr. Pereira graduated in Biological Sciences from the Regional University of Cariri (URCA). Dr. Pereira obtained a PhD in Biotechnology from the Federal University of Pernambuco (UFPE-RENORBIO. He has experience in Microbiology, Toxicology of Natural and Synthetic Products and Biosafety, acting on the following subjects: antibacterial activity, inflammation, toxicity and cancer. He is also a reviewer for several international journals.

L.-H. Sun
Huazhong Agricultural University
Dr. Lv-Hui Sun is a Full Professor in the Department of Animal Nutrition and Feed Science at Huazhong Agricultural University. Before taking the faculty position here, he worked as a Visiting Ph.D. student at the department of Animal Science at Cornell University from 2010 to 2012. He received a Ph.D. degree in Comparative Nutrition between Human and Animal from Sichuan Agricultural University in 2013 and B.S. degree in Animal Science from Wuhan Polytechnic University in 2007. His current research aims at understanding the molecular mechanisms of mycotoxins hepatotoxicity and immunotoxicity and dietary strategies to counteract the toxic effects of mycotoxins.

S.R. Tintino
Universidade Regional do Cariri
Dr. S.R. Tintino completed his graduation in Biological Sciences from the Regional University of Cairri. He further obtained a PhD in Biotechnology from the Federal University of Pernambuco. He is currently serving as a Substitute Professor at the Regional University of Cairri-URCA and he is a Coordinator of the Universal CNP project. He is also a member of the research group of the Laboratory of Microbiology and Molecular Biology. He is experienced in the area of Microbiology, with emphasis on antimicrobial activity of natural products and isolated substances and in the Genetics of Microorganisms with emphasis on mechanisms of inhibition of bacterial efflux pumps. He is a reviewer for several international journals.

N. Vale
University of Porto
Dr. Nuno Vale is an Invited Professor of Pharmacology (Pharmacokinetic and Drug Metabolism) at the Faculty of Pharmacy of the University of Porto. His research interest lies at the intersection between Biomedical Sciences and Pharmacology, namely on the development of new conjugates with peptides and nanoparticles for drug delivery in cancer and central nervous system. His main research focus is also on the Pharmacokinetic and Drug Metabolism of approved drugs for drug repurposing, and in PBPK Modeling and Drug-Drug Interactions.

Y. Wang
Zhejiang University
Dr. Yi Wang is a Professor in College of Pharmaceutical Sciences at Zhejiang University. He received his Ph.D. in Pharmaceutical Analysis from Zhejiang University in 2007. His laboratory is devoted to the modernization of traditional Chinese medicine (TCM). He is especially interested in screening and identifying bioactive compounds from TCM as well as revealing their ADME properties and mechanism of action. Dr. Wang’s lab established a set of bioassays including cellular, zebrafish, and animal models. He has published more than 50 peer-reviewed papers, book and chapters.

J. Zhang
Binzhou Medical University
Professor/Dr. Jiayu Zhang received his Ph.D degree in pharmacognosy (Chemistry of Chinese Materia Medica) from Peking University. He is currently a professor at BIN ZHOU Medical University. During 2011-2019, he worked in Beijing University of Chinese Medicine, which is a famous University of traditional Chinese medicine in China. He is especially interested in metabolism and pharmacokinetics of traditional Chinese medicine. He has published more than 70 peer-reviewed papers.


Ming Hu
University of Houston College of Pharmacy
Houston, TX
View Full Editorial Board

COPE Compliant

Journal History

Current Drug Metabolism was launched in 2000. Dr. Ming Hu serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.75


New Year Offer 2021Covid Resource Center

Related Journals

Related eBooks

eBooks Catalog